Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary ACTH Hypersecretion | 18 | 2024 | 179 | 3.460 |
Why?
|
Pituitary Neoplasms | 37 | 2024 | 1324 | 3.080 |
Why?
|
Acromegaly | 18 | 2022 | 310 | 1.710 |
Why?
|
Adenoma | 26 | 2022 | 2160 | 1.600 |
Why?
|
Cushing Syndrome | 8 | 2021 | 241 | 0.870 |
Why?
|
Petrosal Sinus Sampling | 3 | 2021 | 22 | 0.850 |
Why?
|
Central Nervous System Cysts | 2 | 2020 | 56 | 0.790 |
Why?
|
Adrenocorticotropic Hormone | 11 | 2022 | 618 | 0.740 |
Why?
|
Pituitary Gland | 8 | 2021 | 635 | 0.660 |
Why?
|
Radiosurgery | 5 | 2020 | 1342 | 0.650 |
Why?
|
Sella Turcica | 3 | 2010 | 118 | 0.540 |
Why?
|
Monitoring, Intraoperative | 2 | 2019 | 942 | 0.520 |
Why?
|
Pituitary Diseases | 3 | 2016 | 135 | 0.520 |
Why?
|
Neurosurgical Procedures | 5 | 2020 | 2072 | 0.500 |
Why?
|
Pituitary Apoplexy | 1 | 2014 | 29 | 0.470 |
Why?
|
Salvage Therapy | 1 | 2020 | 1264 | 0.450 |
Why?
|
Antidotes | 1 | 2014 | 138 | 0.440 |
Why?
|
Somatostatin | 7 | 2020 | 447 | 0.430 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 365 | 0.390 |
Why?
|
Prolactinoma | 6 | 2022 | 114 | 0.390 |
Why?
|
Hydrocortisone | 11 | 2024 | 1819 | 0.380 |
Why?
|
Sphenoid Bone | 3 | 2014 | 177 | 0.380 |
Why?
|
Human Growth Hormone | 7 | 2020 | 642 | 0.370 |
Why?
|
Hypopituitarism | 4 | 2023 | 250 | 0.330 |
Why?
|
Nose | 1 | 2012 | 521 | 0.310 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 822 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9280 | 0.270 |
Why?
|
Dopamine Agonists | 3 | 2020 | 352 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 15 | 2021 | 36429 | 0.260 |
Why?
|
Warfarin | 1 | 2014 | 1483 | 0.250 |
Why?
|
Insulin-Like Growth Factor I | 10 | 2020 | 1935 | 0.240 |
Why?
|
Receptors, Somatotropin | 3 | 2020 | 58 | 0.240 |
Why?
|
Hypophysectomy | 2 | 2021 | 114 | 0.230 |
Why?
|
Adrenal Insufficiency | 3 | 2024 | 194 | 0.230 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 2012 | 361 | 0.220 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 4 | 2020 | 49 | 0.220 |
Why?
|
Hyperprolactinemia | 2 | 2022 | 124 | 0.210 |
Why?
|
Brain Injuries | 1 | 2014 | 2053 | 0.200 |
Why?
|
Saliva | 2 | 2018 | 828 | 0.200 |
Why?
|
Brain Neoplasms | 4 | 2020 | 9031 | 0.200 |
Why?
|
Receptors, Somatostatin | 2 | 2020 | 136 | 0.180 |
Why?
|
Body Composition | 5 | 2017 | 2426 | 0.180 |
Why?
|
Retrospective Studies | 26 | 2024 | 80646 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 43 | 0.180 |
Why?
|
Middle Aged | 52 | 2023 | 220920 | 0.170 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 601 | 0.160 |
Why?
|
Frozen Sections | 1 | 2019 | 153 | 0.160 |
Why?
|
Treatment Outcome | 14 | 2023 | 64684 | 0.160 |
Why?
|
Adult | 54 | 2022 | 221203 | 0.150 |
Why?
|
Ependymoma | 3 | 2010 | 320 | 0.150 |
Why?
|
Reoperation | 3 | 2022 | 4303 | 0.150 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 163 | 0.150 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.150 |
Why?
|
Humans | 79 | 2024 | 761572 | 0.150 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 392 | 0.150 |
Why?
|
Albuterol | 1 | 1998 | 213 | 0.150 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1265 | 0.140 |
Why?
|
Male | 53 | 2021 | 360842 | 0.130 |
Why?
|
Female | 58 | 2021 | 392686 | 0.130 |
Why?
|
Intraoperative Period | 2 | 2019 | 510 | 0.130 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2016 | 241 | 0.130 |
Why?
|
Aged | 34 | 2020 | 169310 | 0.130 |
Why?
|
Cytodiagnosis | 1 | 2019 | 447 | 0.130 |
Why?
|
Combined Modality Therapy | 6 | 2020 | 8528 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1157 | 0.120 |
Why?
|
Radiotherapy | 2 | 2020 | 1499 | 0.120 |
Why?
|
Karnofsky Performance Status | 1 | 2014 | 166 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1008 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3123 | 0.110 |
Why?
|
Craniotomy | 2 | 1996 | 741 | 0.110 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1999 | 732 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 1998 | 574 | 0.110 |
Why?
|
Salivary Glands | 1 | 1995 | 229 | 0.110 |
Why?
|
Thyrotropin | 2 | 2014 | 834 | 0.110 |
Why?
|
Craniopharyngioma | 2 | 2010 | 277 | 0.110 |
Why?
|
Choristoma | 1 | 1995 | 206 | 0.110 |
Why?
|
Growth Hormone | 6 | 2022 | 569 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1651 | 0.100 |
Why?
|
Adolescent | 21 | 2021 | 88324 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 1995 | 263 | 0.100 |
Why?
|
International Normalized Ratio | 1 | 2014 | 382 | 0.100 |
Why?
|
Hormone Replacement Therapy | 2 | 2010 | 751 | 0.100 |
Why?
|
Glasgow Coma Scale | 1 | 2014 | 580 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2244 | 0.100 |
Why?
|
Chordoma | 1 | 1995 | 347 | 0.100 |
Why?
|
Patient Care Team | 2 | 2020 | 2521 | 0.090 |
Why?
|
Cysts | 1 | 2016 | 681 | 0.090 |
Why?
|
Plasma | 1 | 2014 | 586 | 0.090 |
Why?
|
Aged, 80 and over | 12 | 2020 | 58986 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7391 | 0.090 |
Why?
|
Brain Stem | 2 | 1995 | 858 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2011 | 329 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2014 | 564 | 0.080 |
Why?
|
Pituitary Gland, Posterior | 1 | 2008 | 42 | 0.080 |
Why?
|
Adrenalectomy | 1 | 2011 | 346 | 0.080 |
Why?
|
Proteins | 3 | 2011 | 6032 | 0.080 |
Why?
|
Recurrence | 4 | 2015 | 8466 | 0.080 |
Why?
|
Nelson Syndrome | 1 | 2007 | 20 | 0.070 |
Why?
|
DNA, Intergenic | 1 | 2008 | 105 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3514 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4513 | 0.070 |
Why?
|
Ki-67 Antigen | 2 | 2008 | 629 | 0.070 |
Why?
|
Gene Silencing | 2 | 2011 | 1509 | 0.070 |
Why?
|
Inhibins | 2 | 2000 | 210 | 0.070 |
Why?
|
Young Adult | 9 | 2020 | 59255 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1033 | 0.070 |
Why?
|
Microsurgery | 1 | 2012 | 795 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14666 | 0.070 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2006 | 63 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2012 | 1475 | 0.060 |
Why?
|
Remission Induction | 3 | 2021 | 2397 | 0.060 |
Why?
|
Morbidity | 2 | 2003 | 1750 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3312 | 0.060 |
Why?
|
Tumor Burden | 2 | 2022 | 1893 | 0.060 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.060 |
Why?
|
Meningioma | 2 | 2010 | 1218 | 0.060 |
Why?
|
ROC Curve | 2 | 2020 | 3579 | 0.060 |
Why?
|
Growth Disorders | 1 | 2009 | 655 | 0.060 |
Why?
|
Child | 10 | 2014 | 80156 | 0.060 |
Why?
|
Quality of Life | 5 | 2023 | 13367 | 0.060 |
Why?
|
Dexamethasone | 2 | 2009 | 1948 | 0.060 |
Why?
|
Postoperative Complications | 7 | 2018 | 15633 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2004 | 573 | 0.050 |
Why?
|
Gene Expression | 3 | 2002 | 7581 | 0.050 |
Why?
|
Intracranial Aneurysm | 2 | 1996 | 1285 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2011 | 7858 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13510 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1814 | 0.050 |
Why?
|
Octreotide | 2 | 2017 | 153 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3424 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2632 | 0.050 |
Why?
|
Prolactin | 2 | 2022 | 625 | 0.050 |
Why?
|
Endoscopy | 1 | 2012 | 1851 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12975 | 0.050 |
Why?
|
Receptors, Growth Factor | 2 | 2000 | 326 | 0.050 |
Why?
|
Carotid Artery Diseases | 1 | 1987 | 877 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15266 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39107 | 0.040 |
Why?
|
Time | 1 | 2021 | 546 | 0.040 |
Why?
|
Asthma | 1 | 1998 | 6234 | 0.040 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1999 | 29 | 0.040 |
Why?
|
Receptors, Neuropeptide | 1 | 1999 | 106 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 26127 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5492 | 0.040 |
Why?
|
Hypothalamic Hormones | 1 | 1999 | 145 | 0.040 |
Why?
|
Matched-Pair Analysis | 1 | 1999 | 284 | 0.040 |
Why?
|
Postoperative Care | 1 | 2005 | 1468 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7967 | 0.040 |
Why?
|
Health Care Costs | 1 | 2012 | 3242 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4812 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2006 | 12794 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1286 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22176 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 12954 | 0.040 |
Why?
|
Ergolines | 1 | 2017 | 57 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1999 | 302 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 768 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2917 | 0.040 |
Why?
|
Hospital Costs | 1 | 2003 | 947 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10212 | 0.040 |
Why?
|
Time Factors | 5 | 2020 | 39970 | 0.030 |
Why?
|
Lipodystrophy | 1 | 2017 | 145 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11076 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1552 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 1 | 1996 | 135 | 0.030 |
Why?
|
Basilar Artery | 1 | 1996 | 205 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1996 | 185 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
Galactorrhea | 1 | 1995 | 23 | 0.030 |
Why?
|
Circadian Rhythm | 2 | 2018 | 2576 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 2011 | 1069 | 0.030 |
Why?
|
Testosterone | 1 | 2006 | 2472 | 0.030 |
Why?
|
Survival Rate | 2 | 1999 | 12725 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12463 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1178 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29629 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13642 | 0.030 |
Why?
|
DNA Methylation | 1 | 2008 | 4399 | 0.030 |
Why?
|
Neuropeptides | 1 | 1999 | 944 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 1998 | 1682 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 702 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54426 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 539 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1998 | 1093 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 393 | 0.030 |
Why?
|
Skull Base | 1 | 1996 | 292 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1563 | 0.030 |
Why?
|
Hospitals, General | 1 | 1997 | 798 | 0.030 |
Why?
|
Statistics as Topic | 1 | 1999 | 2358 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 962 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 1995 | 390 | 0.020 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1991 | 95 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1924 | 0.020 |
Why?
|
Skull Neoplasms | 1 | 1992 | 173 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2872 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 613 | 0.020 |
Why?
|
Cerebellum | 2 | 1996 | 1501 | 0.020 |
Why?
|
Rhinoplasty | 1 | 1995 | 238 | 0.020 |
Why?
|
Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
Endocrinology | 1 | 1997 | 442 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 1991 | 53 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 1997 | 935 | 0.020 |
Why?
|
Blood Glucose | 2 | 2017 | 6391 | 0.020 |
Why?
|
Gonadotropins | 1 | 1991 | 241 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2006 | 10448 | 0.020 |
Why?
|
Spinal Nerves | 1 | 1990 | 91 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2208 | 0.020 |
Why?
|
Aftercare | 1 | 2016 | 914 | 0.020 |
Why?
|
Chondrosarcoma | 1 | 1992 | 296 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3882 | 0.020 |
Why?
|
Sarcoma | 2 | 2008 | 1801 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2003 | 5293 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1520 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2006 | 12341 | 0.020 |
Why?
|
Neurology | 1 | 1997 | 780 | 0.020 |
Why?
|
Neurosurgery | 1 | 1996 | 679 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 1990 | 160 | 0.020 |
Why?
|
Trigeminal Nerve | 1 | 1990 | 248 | 0.020 |
Why?
|
Disabled Persons | 1 | 1998 | 1225 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2006 | 6132 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20099 | 0.020 |
Why?
|
Fathers | 1 | 2011 | 376 | 0.020 |
Why?
|
Encephalocele | 1 | 1989 | 135 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2009 | 14607 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 4575 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2008 | 172 | 0.020 |
Why?
|
Bromocriptine | 1 | 2007 | 93 | 0.020 |
Why?
|
Occipital Lobe | 1 | 1989 | 374 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 2898 | 0.020 |
Why?
|
Lipoproteins | 1 | 2012 | 881 | 0.020 |
Why?
|
Glycoproteins | 1 | 1995 | 2203 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 695 | 0.020 |
Why?
|
Ligation | 1 | 1987 | 448 | 0.020 |
Why?
|
Physicians, Family | 1 | 2008 | 350 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1705 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13255 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2008 | 20571 | 0.020 |
Why?
|
Drug Interactions | 1 | 2009 | 1416 | 0.020 |
Why?
|
Carotid Artery, Internal | 1 | 1987 | 445 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2003 | 26198 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2264 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1990 | 716 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8552 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3963 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1886 | 0.010 |
Why?
|
Chronic Disease | 1 | 1998 | 9319 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4465 | 0.010 |
Why?
|
Family Characteristics | 1 | 2008 | 1004 | 0.010 |
Why?
|
Infant | 2 | 2003 | 36192 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1990 | 1250 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5774 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1116 | 0.010 |
Why?
|
Hormones | 1 | 2006 | 869 | 0.010 |
Why?
|
Olivary Nucleus | 1 | 1982 | 128 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1995 | 4937 | 0.010 |
Why?
|
Cerebellar Cortex | 1 | 1982 | 107 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3341 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41493 | 0.010 |
Why?
|
Mothers | 1 | 2011 | 2198 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42230 | 0.010 |
Why?
|
Activin Receptors | 1 | 2000 | 40 | 0.010 |
Why?
|
Prolactin-Releasing Hormone | 1 | 1999 | 3 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2116 | 0.010 |
Why?
|
Arousal | 1 | 2006 | 1166 | 0.010 |
Why?
|
Thymidine | 1 | 2000 | 299 | 0.010 |
Why?
|
Hypogonadism | 1 | 2006 | 798 | 0.010 |
Why?
|
Reference Values | 2 | 1998 | 4920 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 329 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 360 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1998 | 38 | 0.010 |
Why?
|
Activin Receptors, Type I | 1 | 1999 | 134 | 0.010 |
Why?
|
Activin Receptors, Type II | 1 | 1999 | 123 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 30054 | 0.010 |
Why?
|
Activins | 1 | 2000 | 210 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74213 | 0.010 |
Why?
|
Affect | 1 | 2006 | 1486 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1998 | 225 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3826 | 0.010 |
Why?
|
Cyclins | 1 | 2000 | 594 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6815 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1998 | 6075 | 0.010 |
Why?
|
Emotions | 1 | 2009 | 2739 | 0.010 |
Why?
|
Radiography | 1 | 1987 | 6965 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2006 | 2180 | 0.010 |
Why?
|
United States | 1 | 2003 | 72335 | 0.010 |
Why?
|
MicroRNAs | 1 | 2011 | 3816 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1997 | 249 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16986 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 790 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
Follistatin | 1 | 1995 | 137 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1995 | 208 | 0.010 |
Why?
|
Paranasal Sinuses | 1 | 1996 | 265 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4174 | 0.010 |
Why?
|
Bone Density | 1 | 2006 | 3551 | 0.010 |
Why?
|
Blotting, Western | 1 | 2000 | 5035 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1756 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 1123 | 0.010 |
Why?
|
Estradiol | 1 | 1998 | 1937 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1996 | 1281 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1999 | 4111 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1990 | 113 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10508 | 0.010 |
Why?
|
Mental Disorders | 1 | 2009 | 6845 | 0.010 |
Why?
|
Research | 1 | 1997 | 1982 | 0.000 |
Why?
|
Cognition | 1 | 2006 | 6992 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1990 | 574 | 0.000 |
Why?
|
Base Sequence | 1 | 1999 | 12441 | 0.000 |
Why?
|
Meningomyelocele | 1 | 1989 | 171 | 0.000 |
Why?
|
Cerebellar Diseases | 1 | 1989 | 220 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13446 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1990 | 2561 | 0.000 |
Why?
|
Cerebral Ventricles | 1 | 1989 | 542 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15501 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1997 | 1667 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17635 | 0.000 |
Why?
|
Cytoplasm | 1 | 1990 | 1510 | 0.000 |
Why?
|
Microtubules | 1 | 1990 | 1074 | 0.000 |
Why?
|
Education, Medical, Graduate | 1 | 1997 | 2373 | 0.000 |
Why?
|
Massachusetts | 1 | 1997 | 8830 | 0.000 |
Why?
|
Genetic Variation | 1 | 1998 | 6567 | 0.000 |
Why?
|
Glucose | 1 | 1995 | 4346 | 0.000 |
Why?
|
Anura | 1 | 1982 | 80 | 0.000 |
Why?
|
Cats | 1 | 1982 | 975 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7593 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10766 | 0.000 |
Why?
|
Neural Pathways | 1 | 1982 | 3060 | 0.000 |
Why?
|
Brain Mapping | 1 | 1982 | 6635 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1982 | 22172 | 0.000 |
Why?
|
Mice | 1 | 1982 | 81533 | 0.000 |
Why?
|
Animals | 1 | 1982 | 168467 | 0.000 |
Why?
|